Functional overlaps between XLF and the ATM-dependent DNA double strand break response

DNA Repair

Volumn 16, Issue 1, 2014, Pages 11-22

  Kumar, Vipul ^a   Alt, Frederick W ^a   Oksenych, Valentyn ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

53BP1; ATM; Cernunnos; DNA PKcs; NHEJ; V(D)J recombination

Indexed keywords

53BP1; ATM; CERNUNNOS; DNA-PKCS; NHEJ; V(D)J RECOMBINATION;

ANIMALS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; B-LYMPHOCYTES; DNA BREAKS, DOUBLE-STRANDED; DNA END-JOINING REPAIR; DNA-BINDING PROTEINS; HISTONES; HUMANS; IMMUNOGLOBULIN CLASS SWITCHING; LYMPHOCYTE ACTIVATION; V(D)J RECOMBINATION;

EID: 84894279992     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2014.01.010     Document Type: Article

References (148)

1. Alt F.W., Zhang Y., Meng F.L., Guo C., Schwer B. Mechanisms of programmed DNA lesions and genomic instability in the immune system. Cell 2013, 152:417-429.
2. Boboila C., Alt F.W., Schwer B. Classical and alternative end-joining pathways for repair of lymphocyte-specific and general DNA double-strand breaks. Advances in Immunology 2012, 116:1-49.
3. Zhang Y., Gostissa M., Hildebrand D.G., Becker M.S., Boboila C., Chiarle R., Lewis S., Alt F.W. The role of mechanistic factors in promoting chromosomal translocations found in lymphoid and other cancers. Advances in Immunology 2010, 106:93-133.
4. Gostissa M., Alt F.W., Chiarle R. Mechanisms that promote and suppress chromosomal translocations in lymphocytes. Annual Review of Immunology 2011, 29:319-350.
5. Tonegawa S. Somatic generation of antibody diversity. Nature 1983, 302:575-581.
6. Difilippantonio M.J., McMahan C.J., Eastman Q.M., Spanopoulou E., Schatz D.G. RAG1 mediates signal sequence recognition and recruitment of RAG2 in V(D)J recombination. Cell 1996, 87:253-262.
7. Schatz D.G., Oettinger M.A., Baltimore D. The V(D)J recombination activating gene, RAG-1. Cell 1989, 59:1035-1048.
8. Oettinger M.A., Schatz D.G., Gorka C., Baltimore D. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 1990, 248:1517-1523.
9. McBlane J.F., van Gent D.C., Ramsden D.A., Romeo C., Cuomo C.A., Gellert M., Oettinger M.A. Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps. Cell 1995, 83:387-395.
10. Fugmann S.D., Lee A.I., Shockett P.E., Villey I.J., Schatz D.G. The RAG proteins and V(D)J recombination: complexes, ends, and transposition. Annual Review of Immunology 2000, 18:495-527.
11. Taccioli G.E., Rathbun G., Oltz E., Stamato T., Jeggo P.A., Alt F.W. Impairment of V(D)J recombination in double-strand break repair mutants. Science 1993, 260:207-210.
12. Corneo B., Wendland R.L., Deriano L., Cui X., Klein I.A., Wong S.Y., Arnal S., Holub A.J., Weller G.R., Pancake B.A., Shah S., Brandt V.L., Meek K., Roth D.B. Rag mutations reveal robust alternative end joining. Nature 2007, 449:483-486.
13. Bednarski J.J., Sleckman B.P. Lymphocyte development: integration of DNA damage response signaling. Advances in Immunology 2012, 116:175-204.
14. Desiderio S. Temporal and spatial regulatory functions of the V(D)J recombinase. Seminars in Immunology 2010, 22:362-369.
15. Schatz D.G., Swanson P.C. V(D)J recombination: mechanisms of initiation. Annual Review of Genetics 2011, 45:167-202.
16. Bassing C.H., Swat W., Alt F.W. The mechanism and regulation of chromosomal V(D)J recombination. Cell 2002, 109(Suppl.):S45-S55.
17. Yan C.T., Boboila C., Souza E.K., Franco S., Hickernell T.R., Murphy M., Gumaste S., Geyer M., Zarrin A.A., Manis J.P., Rajewsky K., Alt F.W. IgH class switching and translocations use a robust non-classical end-joining pathway. Nature 2007, 449:478-482.
18. Boboila C., Jankovic M., Yan C.T., Wang J.H., Wesemann D.R., Zhang T., Fazeli A., Feldman L., Nussenzweig A., Nussenzweig M., Alt F.W. Alternative end-joining catalyzes robust IgH locus deletions and translocations in the combined absence of ligase 4 and Ku70. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:3034-3039.
19. Boboila C., Yan C., Wesemann D.R., Jankovic M., Wang J.H., Manis J., Nussenzweig A., Nussenzweig M., Alt F.W. Alternative end-joining catalyzes class switch recombination in the absence of both Ku70 and DNA ligase 4. Journal of Experimental Medicine 2010, 207:417-427.
20. Lieber M.R. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annual Review of Biochemistry 2010, 79:181-211.
21. Rooney S., Chaudhuri J., Alt F.W. The role of the non-homologous end-joining pathway in lymphocyte development. Immunological Reviews 2004, 200:115-131.
22. Featherstone C., Jackson S.P. Ku, a DNA repair protein with multiple cellular functions?. Mutation Research 1999, 434:3-15.
23. Nick McElhinny S.A., Snowden C.M., McCarville J., Ramsden D.A. Ku recruits the XRCC4-ligase IV complex to DNA ends. Molecular and Cellular Biology 2000, 20:2996-3003.
24. Mari P.O., Florea B.I., Persengiev S.P., Verkaik N.S., Bruggenwirth H.T., Modesti M., Giglia-Mari G., Bezstarosti K., Demmers J.A., Luider T.M., Houtsmuller A.B., van Gent D.C. Dynamic assembly of end-joining complexes requires interaction between Ku70/80 and XRCC4. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:18597-18602.
25. Dudley D.D., Chaudhuri J., Bassing C.H., Alt F.W. Mechanism and control of V(D)J recombination versus class switch recombination: similarities and differences. Advances in Immunology 2005, 86:43-112.
26. Shinkai Y., Rathbun G., Lam K.P., Oltz E.M., Stewart V., Mendelsohn M., Charron J., Datta M., Young F., Stall A.M., et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992, 68:855-867.
27. Ma Y., Pannicke U., Schwarz K., Lieber M.R. Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell 2002, 108:781-794.
28. Alt F.W., Baltimore D. Joining of immunoglobulin heavy chain gene segments: implications from a chromosome with evidence of three D-JH fusions. Proceedings of the National Academy of Sciences of the United States of America 1982, 79:4118-4122.
29. Komori T., Okada A., Stewart V., Alt F.W. Lack of N regions in antigen receptor variable region genes of TdT-deficient lymphocytes. Science 1993, 261:1171-1175.
30. Gilfillan S., Dierich A., Lemeur M., Benoist C., Mathis D. Mice lacking TdT: mature animals with an immature lymphocyte repertoire. Science 1993, 261:1175-1178.
31. Gao Y., Chaudhuri J., Zhu C., Davidson L., Weaver D.T., Alt F.W. A targeted DNA-PKcs-null mutation reveals DNA-PK-independent functions for KU in V(D)J recombination. Immunity 1998, 9:367-376.
32. Oksenych V., Kumar V., Liu X., Guo C., Schwer B., Zha S., Alt F.W. Functional redundancy between the XLF and DNA-PKcs DNA repair factors in V(D)J recombination and nonhomologous DNA end joining. Proceedings of the National Academy of Sciences of the United States of America 2013, 110:2234-2239.
33. Zha S., Jiang W., Fujiwara Y., Patel H., Goff P.H., Brush J.W., Dubois R.L., Alt F.W. Ataxia telangiectasia-mutated protein and DNA-dependent protein kinase have complementary V(D)J recombination functions. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:2028-2033.
34. Errami A., He D.M., Friedl A.A., Overkamp W.J., Morolli B., Hendrickson E.A., Eckardt-Schupp F., Oshimura M., Lohman P.H., Jackson S.P., Zdzienicka M.Z. XR-C1, a new CHO cell mutant which is defective in DNA-PKcs, is impaired in both V(D)J coding and signal joint formation. Nucleic Acids Research 1998, 26:3146-3153.
35. Fukumura R., Araki R., Fujimori A., Mori M., Saito T., Watanabe F., Sarashi M., Itsukaichi H., Eguchi-Kasai K., Sato K., Tatsumi K., Abe M. Murine cell line SX9 bearing a mutation in the DNA-PKcs gene exhibits aberrant V(D)J recombination not only in the coding joint but also in the signal joint. Journal of Biological Chemistry 1998, 273:13058-13064.
36. Fukumura R., Araki R., Fujimori A., Tsutsumi Y., Kurimasa A., Li G.C., Chen D.J., Tatsumi K., Abe M. Signal joint formation is also impaired in DNA-dependent protein kinase catalytic subunit knockout cells. Journal of Immunology 2000, 165:3883-3889.
37. Kurimasa A., Ouyang H., Dong L.J., Wang S., Li X., Cordon-Cardo C., Chen D.J., Li G.C. Catalytic subunit of DNA-dependent protein kinase: impact on lymphocyte development and tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:1403-1408.
38. Taccioli G.E., Amatucci A.G., Beamish H.J., Gell D., Xiang X.H., Torres Arzayus M.I., Priestley A., Jackson S.P., Marshak Rothstein A., Jeggo P.A., Herrera V.L. Targeted disruption of the catalytic subunit of the DNA-PK gene in mice confers severe combined immunodeficiency and radiosensitivity. Immunity 1998, 9:355-366.
39. Meek K., Dang V., Lees-Miller S.P. DNA-PK: the means to justify the ends?. Advances in Immunology 2008, 99:33-58.
40. Spagnolo L., Rivera-Calzada A., Pearl L.H., Llorca O. Three-dimensional structure of the human DNA-PKcs/Ku70/Ku80 complex assembled on DNA and its implications for DNA DSB repair. Molecular Cell 2006, 22:511-519.
41. DeFazio L.G., Stansel R.M., Griffith J.D., Chu G. Synapsis of DNA ends by DNA-dependent protein kinase. EMBO Journal 2002, 21:3192-3200.
42. Boboila C., Oksenych V., Gostissa M., Wang J.H., Zha S., Zhang Y., Chai H., Lee C.S., Jankovic M., Saez L.M., Nussenzweig M.C., McKinnon P.J., Alt F.W., Schwer B. Robust chromosomal DNA repair via alternative end-joining in the absence of X-ray repair cross-complementing protein 1 (XRCC1). Proceedings of the National Academy of Sciences of the United States of America 2012, 109:2473-2478.
43. Guirouilh-Barbat J., Huck S., Bertrand P., Pirzio L., Desmaze C., Sabatier L., Lopez B.S. Impact of the KU80 pathway on NHEJ-induced genome rearrangements in mammalian cells. Molecular Cell 2004, 14:611-623.
44. Yan C.T., Kaushal D., Murphy M., Zhang Y., Datta A., Chen C., Monroe B., Mostoslavsky G., Coakley K., Gao Y., Mills K.D., Fazeli A.P., Tepsuporn S., Hall G., Mulligan R., Fox E., Bronson R., De Girolami U., Lee C., Alt F.W. XRCC4 suppresses medulloblastomas with recurrent translocations in p53-deficient mice. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:7378-7383.
45. Gao Y., Ferguson D.O., Xie W., Manis J.P., Sekiguchi J., Frank K.M., Chaudhuri J., Horner J., DePinho R.A., Alt F.W. Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature 2000, 404:897-900.
46. Frank K.M., Sharpless N.E., Gao Y., Sekiguchi J.M., Ferguson D.O., Zhu C., Manis J.P., Horner J., DePinho R.A., Alt F.W. DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway. Molecular Cell 2000, 5:993-1002.
47. Frank K.M., Sekiguchi J.M., Seidl K.J., Swat W., Rathbun G.A., Cheng H.L., Davidson L., Kangaloo L., Alt F.W. Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV. Nature 1998, 396:173-177.
48. Gao Y., Sun Y., Frank K.M., Dikkes P., Fujiwara Y., Seidl K.J., Sekiguchi J.M., Rathbun G.A., Swat W., Wang J., Bronson R.T., Malynn B.A., Bryans M., Zhu C., Chaudhuri J., Davidson L., Ferrini R., Stamato T., Orkin S.H., Greenberg M.E., Alt F.W. A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell 1998, 95:891-902.
49. Li H., Liu N., Rajendran G.K., Gernon T.J., Rockhill J.K., Schwartz J.L., Gu Y. A role for endogenous and radiation-induced DNA double-strand breaks in p53-dependent apoptosis during cortical neurogenesis. Radiation Research 2008, 169:513-522.
50. Gu Y., Sekiguchi J., Gao Y., Dikkes P., Frank K., Ferguson D., Hasty P., Chun J., Alt F.W. Defective embryonic neurogenesis in Ku-deficient but not DNA-dependent protein kinase catalytic subunit-deficient mice. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:2668-2673.
51. Gu Y., Seidl K.J., Rathbun G.A., Zhu C., Manis J.P., van der Stoep N., Davidson L., Cheng H.L., Sekiguchi J.M., Frank K., Stanhope-Baker P., Schlissel M.S., Roth D.B., Alt F.W. Growth retardation and leaky SCID phenotype of Ku70-deficient mice. Immunity 1997, 7:653-665.
52. Karanjawala Z.E., Adachi N., Irvine R.A., Oh E.K., Shibata D., Schwarz K., Hsieh C.L., Lieber M.R. The embryonic lethality in DNA ligase IV-deficient mice is rescued by deletion of Ku: implications for unifying the heterogeneous phenotypes of NHEJ mutants. DNA Repair 2002, 1:1017-1026.
53. Adachi N., Ishino T., Ishii Y., Takeda S., Koyama H. DNA ligase IV-deficient cells are more resistant to ionizing radiation in the absence of Ku70: implications for DNA double-strand break repair. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:12109-12113.
54. Franco S., Murphy M.M., Li G., Borjeson T., Boboila C., Alt F.W. DNA-PKcs and Artemis function in the end-joining phase of immunoglobulin heavy chain class switch recombination. Journal of Experimental Medicine 2008, 205:557-564.
55. Manis J.P., Dudley D., Kaylor L., Alt F.W. IgH class switch recombination to IgG1 in DNA-PKcs-deficient B cells. Immunity 2002, 16:607-617.
56. Rooney S., Alt F.W., Sekiguchi J., Manis J.P. Artemis-independent functions of DNA-dependent protein kinase in Ig heavy chain class switch recombination and development. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:2471-2475.
57. Rooney S., Alt F.W., Lombard D., Whitlow S., Eckersdorff M., Fleming J., Fugmann S., Ferguson D.O., Schatz D.G., Sekiguchi J. Defective DNA repair and increased genomic instability in Artemis-deficient murine cells. Journal of Experimental Medicine 2003, 197:553-565.
58. Rooney S., Sekiguchi J., Zhu C., Cheng H.L., Manis J., Whitlow S., DeVido J., Foy D., Chaudhuri J., Lombard D., Alt F.W. Leaky Scid phenotype associated with defective V(D)J coding end processing in Artemis-deficient mice. Molecular Cell 2002, 10:1379-1390.
59. Difilippantonio M.J., Zhu J., Chen H.T., Meffre E., Nussenzweig M.C., Max E.E., Ried T., Nussenzweig A. DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature 2000, 404:510-514.
60. Vanasse G.J., Halbrook J., Thomas S., Burgess A., Hoekstra M.F., Disteche C.M., Willerford D.M. Genetic pathway to recurrent chromosome translocations in murine lymphoma involves V(D)J recombinase. Journal of Clinical Investigation 1999, 103:1669-1675.
61. Gladdy R.A., Taylor M.D., Williams C.J., Grandal I., Karaskova J., Squire J.A., Rutka J.T., Guidos C.J., Danska J.S. The RAG-1/2 endonuclease causes genomic instability and controls CNS complications of lymphoblastic leukemia in p53/Prkdc-deficient mice. Cancer Cell 2003, 3:37-50.
62. Lim D.S., Vogel H., Willerford D.M., Sands A.T., Platt K.A., Hasty P. Analysis of ku80-mutant mice and cells with deficient levels of p53. Molecular and Cellular Biology 2000, 20:3772-3780.
63. Lee Y., McKinnon P.J. DNA ligase IV suppresses medulloblastoma formation. Cancer Research 2002, 62:6395-6399.
64. Holcomb V.B., Vogel H., Marple T., Kornegay R.W., Hasty P. Ku80 and p53 suppress medulloblastoma that arise independent of Rag-1-induced DSBs. Oncogene 2006, 25:7159-7165.
65. Ahnesorg P., Smith P., Jackson S.P. XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell 2006, 124:301-313.
66. Buck D., Malivert L., de Chasseval R., Barraud A., Fondaneche M.C., Sanal O., Plebani A., Stephan J.L., Hufnagel M., le Deist F., Fischer A., Durandy A., de Villartay J.P., Revy P. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly, Cell 2006, 124:287-299.
67. Li G., Alt F.W., Cheng H.L., Brush J.W., Goff P.H., Murphy M.M., Franco S., Zhang Y., Zha S. Lymphocyte-specific compensation for XLF/cernunnos end-joining functions in V(D)J recombination. Molecular Cell 2008, 31:631-640.
68. Vera G., Rivera-Munoz P., Abramowski V., Malivert L., Lim A., Bole-Feysot C., Martin C., Florkin B., Latour S., Revy P., de Villartay J.P. Cernunnos deficiency reduces thymocyte life span and alters the T cell repertoire in mice and humans. Molecular and Cellular Biology 2013, 33:701-711.
69. Liu X., Jiang W., Dubois R.L., Yamamoto K., Wolner Z., Zha S. Overlapping functions between XLF repair protein and 53BP1 DNA damage response factor in end joining and lymphocyte development. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:3903-3908.
70. Oksenych V., Alt F.W., Kumar V., Schwer B., Wesemann D.R., Hansen E., Patel H., Su A., Guo C. Functional redundancy between repair factor XLF and damage response mediator 53BP1 in V(D)J recombination and DNA repair. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:2455-2460.
71. Zha S., Guo C., Boboila C., Oksenych V., Cheng H.L., Zhang Y., Wesemann D.R., Yuen G., Patel H., Goff P.H., Dubois R.L., Alt F.W. ATM damage response and XLF repair factor are functionally redundant in joining DNA breaks. Nature 2011, 469:250-254.
72. Price B.D., D'Andrea A.D. Chromatin remodeling at DNA double-strand breaks. Cell 2013, 152:1344-1354.
73. Ciccia A., Elledge S.J. The DNA damage response: making it safe to play with knives. Molecular Cell 2010, 40:179-204.
74. Derheimer F.A., Kastan M.B. Multiple roles of ATM in monitoring and maintaining DNA integrity. FEBS Letters 2010, 584:3675-3681.
75. Barlow C., Hirotsune S., Paylor R., Liyanage M., Eckhaus M., Collins F., Shiloh Y., Crawley J.N., Ried T., Tagle D., Wynshaw-Boris A. ATM-deficient mice: a paradigm of ataxia telangiectasia. Cell 1996, 86:159-171.
76. Rotman G., Shiloh Y. ATM: a mediator of multiple responses to genotoxic stress. Oncogene 1999, 18:6135-6144.
77. Bassing C.H., Suh H., Ferguson D.O., Chua K.F., Manis J., Eckersdorff M., Gleason M., Bronson R., Lee C., Alt F.W. Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Cell 2003, 114:359-370.
78. Bredemeyer A.L., Sharma G.G., Huang C.Y., Helmink B.A., Walker L.M., Khor K.C., Nuskey B., Sullivan K.E., Pandita T.K., Bassing C.H., Sleckman B.P. ATM stabilizes DNA double-strand-break complexes during V(D)J recombination. Nature 2006, 442:466-470.
79. Franco S., Gostissa M., Zha S., Lombard D.B., Murphy M.M., Zarrin A.A., Yan C., Tepsuporn S., Morales J.C., Adams M.M., Lou Z., Bassing C.H., Manis J.P., Chen J., Carpenter P.B., Alt F.W. H2AX prevents DNA breaks from progressing to chromosome breaks and translocations. Molecular Cell 2006, 21:201-214.
80. Stewart G.S., Wang B., Bignell C.R., Taylor A.M., Elledge S.J. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature 2003, 421:961-966.
81. Lou Z., Minter-Dykhouse K., Franco S., Gostissa M., Rivera M.A., Celeste A., Manis J.P., van Deursen J., Nussenzweig A., Paull T.T., Alt F.W., Chen J. MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals. Molecular Cell 2006, 21:187-200.
82. Stucki M., Clapperton J.A., Mohammad D., Yaffe M.B., Smerdon S.J., Jackson S.P. MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell 2005, 123:1213-1226.
83. Chapman J.R., Jackson S.P. Phospho-dependent interactions between NBS1 and MDC1 mediate chromatin retention of the MRN complex at sites of DNA damage. EMBO Reports 2008, 9:795-801.
84. Melander F., Bekker-Jensen S., Falck J., Bartek J., Mailand N., Lukas J. Phosphorylation of SDT repeats in the MDC1N terminus triggers retention of NBS1 at the DNA damage-modified chromatin. Journal of Cell Biology 2008, 181:213-226.
85. Bekker-Jensen S., Mailand N. Assembly and function of DNA double-strand break repair foci in mammalian cells. DNA Repair 2010, 9:1219-1228.
86. Stewart G.S. Solving the RIDDLE of 53BP1 recruitment to sites of damage. Cell Cycle 2009, 8:1532-1538.
87. Noon A.T., Goodarzi A.A. 53BP1-mediated DNA double strand break repair: insert bad pun here. DNA Repair 2011, 10:1071-1076.
88. Fradet-Turcotte A., Canny M.D., Escribano-Diaz C., Orthwein A., Leung C.C., Huang H., Landry M.C., Kitevski-Leblanc J., Noordermeer S.M., Sicheri F., Durocher D. 53BP1 is a reader of the DNA-damage-induced H2A Lys 15 ubiquitin mark. Nature 2013.
89. Bassing C.H., Alt F.W. H2AX may function as an anchor to hold broken chromosomal DNA ends in close proximity. Cell Cycle 2004, 3:149-153.
90. Helmink B.A., Tubbs A.T., Dorsett Y., Bednarski J.J., Walker L.M., Feng Z., Sharma G.G., McKinnon P.J., Zhang J., Bassing C.H., Sleckman B.P. H2AX prevents CtIP-mediated DNA end resection and aberrant repair in G1-phase lymphocytes. Nature 2011, 469:245-249.
91. Callen E., Di Virgilio M., Kruhlak M.J., Nieto-Soler M., Wong N., Chen H.T., Faryabi R.B., Polato F., Santos M., Starnes L.M., Wesemann D.R., Lee J.E., Tubbs A., Sleckman B.P., Daniel J.A., Ge K., Alt F.W., Fernandez-Capetillo O., Nussenzweig M.C., Nussenzweig A. 53BP1 mediates productive and mutagenic DNA repair through distinct phosphoprotein interactions. Cell 2013, 153:1266-1280.
92. Bothmer A., Robbiani D.F., Feldhahn N., Gazumyan A., Nussenzweig A., Nussenzweig M.C. 53BP1 regulates DNA resection and the choice between classical and alternative end joining during class switch recombination. Journal of Experimental Medicine 2010, 207:855-865.
93. Bunting S.F., Callen E., Wong N., Chen H.T., Polato F., Gunn A., Bothmer A., Feldhahn N., Fernandez-Capetillo O., Cao L., Xu X., Deng C.X., Finkel T., Nussenzweig M., Stark J.M., Nussenzweig A. 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell 2010, 141:243-254.
94. Escribano-Diaz C., Orthwein A., Fradet-Turcotte A., Xing M., Young J.T., Tkac J., Cook M.A., Rosebrock A.P., Munro M., Canny M.D., Xu D., Durocher D. A cell cycle-dependent regulatory circuit composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair pathway choice. Molecular Cell 2013, 49:872-883.
95. McKinnon P.J. ATM and the molecular pathogenesis of ataxia telangiectasia. Annual Review of Pathology 2012, 7:303-321.
96. Shiloh Y. Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. Annual Review of Genetics 1997, 31:635-662.
97. Zha S., Bassing C.H., Sanda T., Brush J.W., Patel H., Goff P.H., Murphy M.M., Tepsuporn S., Gatti R.A., Look A.T., Alt F.W. ATM-deficient thymic lymphoma is associated with aberrant tcrd rearrangement and gene amplification. Journal of Experimental Medicine 2010, 207:1369-1380.
98. Lavin M.F. The appropriateness of the mouse model for ataxia-telangiectasia: neurological defects but no neurodegeneration. DNA Repair 2013, 12:612-619.
99. Elson A., Wang Y., Daugherty C.J., Morton C.C., Zhou F., Campos-Torres J., Leder P. Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:13084-13089.
100. Sekiguchi J., Ferguson D.O., Chen H.T., Yang E.M., Earle J., Frank K., Whitlow S., Gu Y., Xu Y., Nussenzweig A., Alt F.W. Genetic interactions between ATM and the nonhomologous end-joining factors in genomic stability and development. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:3243-3248.
101. Zha S., Sekiguchi J., Brush J.W., Bassing C.H., Alt F.W. Complementary functions of ATM and H2AX in development and suppression of genomic instability. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:9302-9306.
102. Larmonie N.S., Dik W.A., Meijerink J.P., Homminga I., van Dongen J.J., Langerak A.W. Breakpoint sites disclose the role of the V(D)J recombination machinery in the formation of T-cell receptor (TCR) and non-TCR associated aberrations in T-cell acute lymphoblastic leukemia. Haematologica 2013, 98:1173-1184.
103. Gapud E.J., Dorsett Y., Yin B., Callen E., Bredemeyer A., Mahowald G.K., Omi K.Q., Walker L.M., Bednarski J.J., McKinnon P.J., Bassing C.H., Nussenzweig A., Sleckman B.P. Ataxia telangiectasia mutated (ATM) and DNA-PKcs kinases have overlapping activities during chromosomal signal joint formation. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:2022-2027.
104. Bassing C.H., Chua K.F., Sekiguchi J., Suh H., Whitlow S.R., Fleming J.C., Monroe B.C., Ciccone D.N., Yan C., Vlasakova K., Livingston D.M., Ferguson D.O., Scully R., Alt F.W. Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:8173-8178.
105. Manis J.P., Morales J.C., Xia Z., Kutok J.L., Alt F.W., Carpenter P.B. 53BP1 links DNA damage-response pathways to immunoglobulin heavy chain class-switch recombination. Nature Immunology 2004, 5:481-487.
106. Celeste A., Petersen S., Romanienko P.J., Fernandez-Capetillo O., Chen H.T., Sedelnikova O.A., Reina-San-Martin B., Coppola V., Meffre E., Difilippantonio M.J., Redon C., Pilch D.R., Olaru A., Eckhaus M., Camerini-Otero R.D., Tessarollo L., Livak F., Manova K., Bonner W.M., Nussenzweig M.C., Nussenzweig A. Genomic instability in mice lacking histone H2AX. Science 2002, 296:922-927.
107. Celeste A., Difilippantonio S., Difilippantonio M.J., Fernandez-Capetillo O., Pilch D.R., Sedelnikova O.A., Eckhaus M., Ried T., Bonner W.M., Nussenzweig A. H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell 2003, 114:371-383.
108. Ward I.M., Minn K., van Deursen J., Chen J. p53 Binding protein 53BP1 is required for DNA damage responses and tumor suppression in mice. Molecular and Cellular Biology 2003, 23:2556-2563.
109. Morales J.C., Franco S., Murphy M.M., Bassing C.H., Mills K.D., Adams M.M., Walsh N.C., Manis J.P., Rassidakis G.Z., Alt F.W., Carpenter P.B. 53BP1 and p53 synergize to suppress genomic instability and lymphomagenesis. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:3310-3315.
110. Ward I.M., Reina-San-Martin B., Olaru A., Minn K., Tamada K., Lau J.S., Cascalho M., Chen L., Nussenzweig A., Livak F., Nussenzweig M.C., Chen J. 53BP1 is required for class switch recombination. Journal of Cell Biology 2004, 165:459-464.
111. Difilippantonio S., Gapud E., Wong N., Huang C.Y., Mahowald G., Chen H.T., Kruhlak M.J., Callen E., Livak F., Nussenzweig M.C., Sleckman B.P., Nussenzweig A. 53BP1 facilitates long-range DNA end-joining during V(D)J recombination. Nature 2008, 456:529-533.
112. Ward I.M., Difilippantonio S., Minn K., Mueller M.D., Molina J.R., Yu X., Frisk C.S., Ried T., Nussenzweig A., Chen J. 53BP1 cooperates with p53 and functions as a haploinsufficient tumor suppressor in mice. Molecular and Cellular Biology 2005, 25:10079-10086.
113. Jankovic M., Feldhahn N., Oliveira T.Y., Silva I.T., Kieffer-Kwon K.R., Yamane A., Resch W., Klein I., Robbiani D.F., Casellas R., Nussenzweig M.C. 53BP1 alters the landscape of DNA rearrangements and suppresses AID-induced B cell lymphoma. Molecular Cell 2013, 49:623-631.
114. Moshous D., Callebaut I., de Chasseval R., Corneo B., Cavazzana-Calvo M., Le Deist F., Tezcan I., Sanal O., Bertrand Y., Philippe N., Fischer A., de Villartay J.P. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 2001, 105:177-186.
115. van der Burg M., Ijspeert H., Verkaik N.S., Turul T., Wiegant W.W., Morotomi-Yano K., Mari P.O., Tezcan I., Chen D.J., Zdzienicka M.Z., van Dongen J.J., van Gent D.C. A DNA-PKcs mutation in a radiosensitive T-B-SCID patient inhibits Artemis activation and nonhomologous end-joining. Journal of Clinical Investigation 2009, 119:91-98.
116. Du L., Peng R., Bjorkman A., Filipe de Miranda N., Rosner C., Kotnis A., Berglund M., Liu C., Rosenquist R., Enblad G., Sundstrom C., Hojjat-Farsangi M., Rabbani H., Teixeira M.R., Revy P., Durandy A., Zeng Y., Gennery A.R., de Villartay J.P., Pan-Hammarstrom Q. Cernunnos influences human immunoglobulin class switch recombination and may be associated with B cell lymphomagenesis. Journal of Experimental Medicine 2012, 209:291-305.
117. Malivert L., Ropars V., Nunez M., Drevet P., Miron S., Faure G., Guerois R., Mornon J.P., Revy P., Charbonnier J.B., Callebaut I., de Villartay J.P. Delineation of the Xrcc4-interacting region in the globular head domain of cernunnos/XLF. Journal of Biological Chemistry 2010, 285:26475-26483.
118. Zha S., Alt F.W., Cheng H.L., Brush J.W., Li G. Defective DNA repair and increased genomic instability in Cernunnos-XLF-deficient murine ES cells. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:4518-4523.
119. Zhu C., Mills K.D., Ferguson D.O., Lee C., Manis J., Fleming J., Gao Y., Morton C.C., Alt F.W. Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell 2002, 109:811-821.
120. Lee Y., McKinnon P.J. Responding to DNA double strand breaks in the nervous system. Neuroscience 2007, 145:1365-1374.
121. Mahaney B.L., Hammel M., Meek K., Tainer J.A., Lees-Miller S.P. XRCC4 and XLF form long helical protein filaments suitable for DNA end protection and alignment to facilitate DNA double strand break repair. Biochemistry and Cell Biology 2013, 91:31-41.
122. Bryans M., Valenzano M.C., Stamato T.D. Absence of DNA ligase IV protein in XR-1 cells: evidence for stabilization by XRCC4. Mutation Research 1999, 433:53-58.
123. Grawunder U., Wilm M., Wu X., Kulesza P., Wilson T.E., Mann M., Lieber M.R. Activity of DNA ligase IV stimulated by complex formation with XRCC4 protein in mammalian cells. Nature 1997, 388:492-495.
124. Andres S.N., Vergnes A., Ristic D., Wyman C., Modesti M., Junop M. A human XRCC4-XLF complex bridges DNA. Nucleic Acids Research 2012, 40:1868-1878.
125. Hammel M., Rey M., Yu Y., Mani R.S., Classen S., Liu M., Pique M.E., Fang S., Mahaney B.L., Weinfeld M., Schriemer D.C., Lees-Miller S.P., Tainer J.A. XRCC4 protein interactions with XRCC4-like factor (XLF) create an extended grooved scaffold for DNA ligation and double strand break repair. Journal of Biological Chemistry 2011, 286:32638-32650.
126. Ropars V., Drevet P., Legrand P., Baconnais S., Amram J., Faure G., Marquez J.A., Pietrement O., Guerois R., Callebaut I., Le Cam E., Revy P., de Villartay J.P., Charbonnier J.B. Structural characterization of filaments formed by human Xrcc4-Cernunnos/XLF complex involved in nonhomologous DNA end-joining. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:12663-12668.
127. Wu Q., Ochi T., Matak-Vinkovic D., Robinson C.V., Chirgadze D.Y., Blundell T.L. Non-homologous end-joining partners in a helical dance: structural studies of XLF-XRCC4 interactions. Biochemical Society Transactions 2011, 39:1387-1392. (suppl. 1382 pp. following 1392).
128. Lu H., Pannicke U., Schwarz K., Lieber M.R. Length-dependent binding of human XLF to DNA and stimulation of XRCC4.DNA ligase IV activity. Journal of Biological Chemistry 2007, 282:11155-11162.
129. Roy S., Andres S.N., Vergnes A., Neal J.A., Xu Y., Yu Y., Lees-Miller S.P., Junop M., Modesti M., Meek K. XRCC4's interaction with XLF is required for coding (but not signal) end joining. Nucleic Acids Research 2012, 40:1684-1694.
130. Deriano L., Roth D.B. Modernizing the nonhomologous end-joining repertoire: alternative and classical NHEJ share the stage. Annual Review of Genetics 2013, 47:433-455.
131. Agrawal A., Schatz D.G. RAG1 and RAG2 form a stable postcleavage synaptic complex with DNA containing signal ends in V(D)J recombination. Cell 1997, 89:43-53.
132. Hiom K., Gellert M. A stable RAG1-RAG2-DNA complex that is active in V(D)J cleavage. Cell 1997, 88:65-72.
133. Jones J.M., Gellert M. Intermediates in V(D)J recombination: a stable RAG1/2 complex sequesters cleaved RSS ends. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:12926-12931.
134. Raval P., Kriatchko A.N., Kumar S., Swanson P.C. Evidence for Ku70/Ku80 association with full-length RAG1. Nucleic Acids Research 2008, 36:2060-2072.
135. Chen H.T., Bhandoola A., Difilippantonio M.J., Zhu J., Brown M.J., Tai X., Rogakou E.P., Brotz T.M., Bonner W.M., Ried T., Nussenzweig A. Response to RAG-mediated VDJ cleavage by NBS1 and gamma-H2AX. Science 2000, 290:1962-1965.
136. Savic V., Yin B., Maas N.L., Bredemeyer A.L., Carpenter A.C., Helmink B.A., Yang-Iott K.S., Sleckman B.P., Bassing C.H. Formation of dynamic gamma-H2AX domains along broken DNA strands is distinctly regulated by ATM and MDC1 and dependent upon H2AX densities in chromatin. Molecular Cell 2009, 34:298-310.
137. Bassing C.H., Alt F.W. The cellular response to general and programmed DNA double strand breaks. DNA Repair 2004, 3:781-796.
138. Paull T.T., Rogakou E.P., Yamazaki V., Kirchgessner C.U., Gellert M., Bonner W.M. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Current Biology 2000, 10:886-895.
139. Burma S., Chen B.P., Murphy M., Kurimasa A., Chen D.J. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. Journal of Biological Chemistry 2001, 276:42462-42467.
140. Callen E., Jankovic M., Wong N., Zha S., Chen H.T., Difilippantonio S., Di Virgilio M., Heidkamp G., Alt F.W., Nussenzweig A., Nussenzweig M. Essential role for DNA-PKcs in DNA double-strand break repair and apoptosis in ATM-deficient lymphocytes. Molecular Cell 2009, 34:285-297.
141. Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R., Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007, 316:1160-1166.
142. Maser R.S., Monsen K.J., Nelms B.E., Petrini J.H. hMre11 and hRad50 nuclear foci are induced during the normal cellular response to DNA double-strand breaks. Molecular and Cellular Biology 1997, 17:6087-6096.
143. Rogakou E.P., Boon C., Redon C., Bonner W.M. Megabase chromatin domains involved in DNA double-strand breaks in vivo. Journal of Cell Biology 1999, 146:905-916.
144. Revy P., Malivert L., de Villartay J.P. Cernunnos-XLF, a recently identified non-homologous end-joining factor required for the development of the immune system. Current Opinion in Allergy and Clinical Immunology 2006, 6:416-420.
145. Riballo E., Woodbine L., Stiff T., Walker S.A., Goodarzi A.A., Jeggo P.A. XLF-Cernunnos promotes DNA ligase IV-XRCC4 re-adenylation following ligation. Nucleic Acids Research 2009, 37:482-492.
146. Gapud E.J., Lee B.S., Mahowald G.K., Bassing C.H., Sleckman B.P. Repair of chromosomal RAG-mediated DNA breaks by mutant RAG proteins lacking phosphatidylinositol 3-like kinase consensus phosphorylation sites. Journal of Immunology 2011, 187:1826-1834.
147. Lavin M.F. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nature Reviews Molecular Cell Biology 2008, 9:759-769.
148. Ambrose M., Gatti R.A. Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions. Blood 2013, 121:4036-4045.